IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,867,488 | -18.9% | 731,607 | +49.9% | 0.02% | -17.9% |
| Q1 2024 | $7,232,723 | +54.4% | 488,038 | -15.3% | 0.03% | +133.3% |
| Q4 2023 | $4,685,335 | +64.6% | 576,302 | -7.9% | 0.01% | +20.0% |
| Q3 2023 | $2,846,940 | +296.6% | 625,701 | +513.6% | 0.01% | +400.0% |
| Q2 2023 | $717,925 | +95.1% | 101,978 | +69.3% | 0.00% | +100.0% |
| Q1 2023 | $368,011 | -55.9% | 60,231 | -53.9% | 0.00% | -50.0% |
| Q4 2022 | $835,013 | +33.0% | 130,675 | +99.4% | 0.00% | +100.0% |
| Q3 2022 | $628,000 | -52.8% | 65,538 | -45.6% | 0.00% | -50.0% |
| Q2 2022 | $1,331,000 | +7294.4% | 120,522 | +11153.2% | 0.00% | – |
| Q1 2022 | $18,000 | -97.1% | 1,071 | -96.7% | 0.00% | -100.0% |
| Q4 2021 | $629,000 | -84.0% | 32,935 | -79.4% | 0.00% | -75.0% |
| Q3 2021 | $3,939,000 | +787.2% | 159,744 | +1038.2% | 0.00% | +300.0% |
| Q1 2021 | $444,000 | -70.8% | 14,035 | -69.6% | 0.00% | -80.0% |
| Q3 2020 | $1,518,000 | +354.5% | 46,117 | +238.2% | 0.01% | +66.7% |
| Q2 2019 | $334,000 | +145.6% | 13,634 | -11.5% | 0.00% | +200.0% |
| Q4 2018 | $136,000 | +51.1% | 15,403 | +118.6% | 0.00% | 0.0% |
| Q2 2018 | $90,000 | +8900.0% | 7,045 | +5674.6% | 0.00% | – |
| Q3 2017 | $1,000 | -96.8% | 122 | -97.1% | 0.00% | – |
| Q2 2017 | $31,000 | – | 4,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $76,661,488 | 13.08% |
| MPM BioImpact LLC | 2,149,550 | $13,735,625 | 3.56% |
| Ghost Tree Capital, LLC | 1,300,000 | $8,307,000 | 3.55% |
| Finepoint Capital LP | 1,545,589 | $9,876 | 3.19% |
| Perceptive Advisors | 9,971,780 | $63,719,674 | 1.79% |
| Affinity Asset Advisors, LLC | 375,000 | $2,396,250 | 0.94% |
| Long Focus Capital Management, LLC | 2,061,814 | $13,174,991 | 0.91% |
| Avoro Capital Advisors LLC | 7,020,000 | $44,857,800 | 0.67% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,822,080 | $11,643,091 | 0.67% |
| Parametrica Management Ltd | 47,900 | $305,602 | 0.63% |